A lawsuit was filed by an investor in shares of Hospira, Inc. (NYSE:HSP) in effort to stop the proposed takeover and NYSE:HSP stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 02/23/2015 -- An investor, who currently holds shares of Hospira, Inc. (NYSE:HSP), filed a lawsuit in effort to halt the proposed takeover of Hospira, Inc. by Pfizer Inc.
Investors who purchased shares of Hospira, Inc. (NYSE:HSP) and currently hold any of those NYSE:HSP shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The plaintiff alleges that the defendants breached their fiduciary duties owed to NYSE:HSP stockholders by agreeing to sell Hospira, Inc. too cheaply via an unfair process to Pfizer Inc.
On February 5, 2015, Pfizer Inc. (NYSE: PFE) and Hospira, Inc. (NYSE: HSP) announced that they have entered into a merger agreement under which Pfizer will acquire Hospira for $90 a share in cash for a total enterprise value of approximately $17 billion.
However, the plaintiff claims that the $90-offer is too low and undervalues Hospira, Inc. In addition, the plaintiff claims that the process is also unfair to NYSE:HSP stockholders
Shares of Hospira, Inc. (NYSE:HSP) closed on February 19, 2015, at $87.44 per share.
Those who are current investors in Hospira, Inc. (NYSE:HSP) shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com